Aarey Drugs & Pharmaceuticals News

Aarey Drugs sets AGM book closure dates

Aarey Drugs & Pharmaceuticals has announced the book closure period for its 36th Annual General Meeting. The registers will remain closed from September 24 to September 30, 2026.

Aarey Drugs board meets on May 29

Aarey Drugs & Pharmaceuticals Ltd. board meets on May 29, 2026, to consider Q4 and FY26 audited results. Trading window closed.

Aarey Drugs Submits Q4 FY26 Compliance Certificate

Aarey Drugs & Pharmaceuticals submitted its quarterly compliance certificate under SEBI regulations for quarter ended March 31, 2026, confirming proper handling of dematerialised securities.

Aarey Drugs Q3FY26 Revenue Drops 28% to ₹9,642.63 Lakhs

Aarey Drugs & Pharmaceuticals reported Q3FY26 revenue of ₹9,642.63 lakhs, down from ₹13,378.86 lakhs in Q3FY25. Net profit declined to ₹56.95 lakhs from ₹71.80 lakhs year-on-year.

Aarey Drugs Reports Q2 FY2026 Financial Results with Fixed Asset Purchases

Aarey Drugs and Pharmaceuticals Limited approved its unaudited financial results for the quarter and half year ended September 30, 2025, along with statements of assets, liabilities, and cash flow. The company purchased certain fixed assets during the reporting period that are not yet ready for intended use, with depreciation to commence once assets are fully installed and commissioned.